safety of glp-1 receptor agonists Potential Use and GIP/GLP-1 for Respiratory Disorders: Where Are We at? GLP-1 receptor agonists are transforming

GLP-1RAs may help alleviate myocardial damage linked to chronic hyperglycaemia

The risk of pancreatitis can be minimized by addressing and mitigating risk factors from previous episodes, regulating the rate of weight loss by adjusting the GLP-1 receptor agonist dose and the content and frequency of meals, closely monitoring patients during GLP-1 receptor agonist therapy, and implementing appropriate precautionary measures

Trial results look promising, but retatrutide is not FDA-approved

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are transforming the way we approach weight loss

Healthcare provider consultation is advisable before use, particularly for individuals taking prescription medications